Arcadia Biosciences Inc (17D.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 07:26PM CEST
| Previous close | 1.8200 |
| Open | 1.7900 |
| Bid | 1.7600 x N/A |
| Ask | 1.8700 x N/A |
| Day's range | 1.7600 - 1.8300 |
| 52-week range | 1.7200 - 5.8000 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksArcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireArcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference Call
DALLAS, April 25, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2024 after market close on May 9, 2024.
ZacksArcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y
Arcadia Biosciences (RKDA) reports improved top-line results in the fourth quarter of 2023, which is aided by higher GoodWheat and GLA revenues.
© 2024 Yahoo. All rights reserved.